BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 5:17:00 PM | Browse: 1823 | Download: 1615
 |
Received |
|
2013-05-20 08:50 |
|
Peer-Review Started |
|
2013-05-20 20:39 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2013-07-20 22:51 |
|
Revised |
|
2013-07-22 21:37 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2013-08-20 12:09 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2013-08-20 13:36 |
|
Articles in Press |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2013-09-18 18:20 |
|
Publish the Manuscript Online |
|
2013-11-19 16:17 |
| Category |
Rheumatology |
| Manuscript Type |
Review |
| Article Title |
Juvenile idiopathic arthritis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Balahan Makay, Erbil Unsal and Ozgur Kasapcopur |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ozgur Kasapcopur, Professor of Pediatrics, Department of Pediatric Rheumatology, Cerrahpasa Medical Faculty, Istanbul University, Paşa Sk, 34098 Istanbul, Turkey. ozgurkc@istanbul.edu.tr |
| Key Words |
Juvenile idiopathic arthritis; Classification; Etiopathogenesis; Treatment; Prognosis; Outcome |
| Core Tip |
Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatologic disease in children. Diagnosis of JIA is based on the history and physical examination findings. There is not a diagnostic laboratory test for JIA. Recent advances in the understanding of the immune system pathways involved in inflammation and self-tolerance have provided new targets for treatment of JIA. Biologic agents targeting key cytokines implicated in JIA, suh as tumor necrosis factor ?, interleukin (IL)-1, and IL-6 as well as signaling molecules involved in the regulation of B-cell and T-cell lymphocyte responses, have promising results. |
| Publish Date |
2013-11-19 16:17 |
| Citation |
Makay B, Unsal E, Kasapcopur O. Juvenile idiopathic arthritis.World J Rheumatol 2013; 3(3): 16-24 |
| URL |
http://www.wjgnet.com/2220-3214/full/v3/i3/16.htm |
| DOI |
http://dx.doi.org/10.5499/wjr.v3.i3.16 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
